Clinical and epidemiological characteristics of individuals resistant to M. tuberculosis infection in a longitudinal TB household contact study in Kampala, Uganda

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Ma, Ningning ^a   Zalwango, Sarah ^b   Malone, LaShaunda L ^a,b   Nsereko, Mary ^b   Wampande, Eddie M ^c   Thiel, Bonnie A ^a,b   Okware, Brenda ^b   Igo, Robert P ^a   Joloba, Moses L ^b,c   Mupere, Ezekiel ^a,b,c   Mayanja Kizza, Harriet ^b,c   Boom, W H ^a,b   Stein, Catherine M ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

^c MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

Author keywords

Exposure; Household characteristics; Latent Mtb infection; PPD test; Transmission risk factors

Indexed keywords

BCG VACCINE; TUBERCULIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BCG VACCINATION; CHILD; CONTACT EXAMINATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOUSEHOLD; HUMAN; INFECTION RESISTANCE; LONG TERM EXPOSURE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; OBSERVATIONAL STUDY; PHENOTYPE; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; SCHOOL CHILD; TUBERCULIN TEST; TUBERCULOSIS; UGANDA; ADAPTIVE IMMUNITY; FAMILY SIZE; IMMUNOLOGY; INFANT; TRANSMISSION; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FAMILY CHARACTERISTICS; FEMALE; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; PREVALENCE; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS, MULTIDRUG-RESISTANT; UGANDA;

EID: 84902930785     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-352     Document Type: Article

References (33)

1. Guwatudde D, Zalwango S, Kamya MR, Debanne SM, Diaz MI, Okwera A, Mugerwa RD, King C, Whalen CC. Burden of tuberculosis in Kampala, Uganda. Bull World Health Organ 2003, 81:799-805.
2. Guwattude D, Nakakeeto M, Jones-Lopez E, Maganda A, Chiunda A, Mugerwa RD, Ellner JJ, Bukenya G, Whalen CC. Tuberculosis in household contacts of infectious cases in Kampala, Uganda. Am J Epidemiol 2003, 158:887-898.
3. Chapman JS, Dyerly MD. Social and other factors in intrafamilial transmission of tuberculosis. Am Rev Respir Dis 1964, 90:48-60.
4. Lienhardt C, Sillah J, Fielding K, Donkor S, Manneh K, Warndorff D, Bennett S, McAdam KPWJ. Risk factors for tuberculosis infection in children in contact with infectious tuberculosis cases in The Gambia, West Africa. Pediatrics 2003, 111:e608-e614.
5. Lienhardt C, Fielding K, Sillah J, Tunkara A, Donkor S, Manneh K, Warndorff D, McAdam KPWJ, Bennett S. Risk factors for tuberculosis infection in sub-Saharan Africa: A contact study in The Gambia. Am J Respir Crit Care Med 2003, 168:448-455.
6. Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, Nguyen CH. Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med 2000, 162:2033-2038.
7. Almeida L, Barbieri M, Carvalho Da Paixao A, Cuevas L. User of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a populatoin with high Calmette-Guérin bacillus coverage. Pediatr Infect Dis 2001, 20:1061-1065.
8. Comstock G. Epidemiology of tuberculosis. Am Rev Respir Dis 1982, 125:8-15.
9. Stein CM, Zalwango S, Malone LL, Won S, Mayanja-Kizza H, Mugerwa RD, Leontiev DV, Thompson CL, Cartier KC, Elston RC, Iyengar SK, Boom WH, Whalen CC. Genome scan of M. tuberculosis infection and disease in Ugandans. PLoS ONE 2008, 3:e4094.
10. Salaman MR. Persistent negative tuberculin reactors. Tuberculosis (Edinb.) 2013, 93(6):688-689.
11. Mandalakas AM, Kirchner HL, Lombard C, Walzl G, Grewal HM, Gie RP, Hesseling AC. Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection. Int J Tuberc Lung Dis 2012, 16:1033-1039.
12. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Kalantri S, Reingold AL, Colford JM, Riley LW, Menzies D. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006, 174:349-355.
13. Lee SH, Lew WJ, Kim HJ, Lee HK, Lee YM, Cho CH, Lee EJ, Lee DY, Ryu SW, WY OH, Kim SO, Shim TS. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak. Respir Med 2010, 104:448-453.
14. Park JS, Lee JS, Kim MY, Lee CH, Yoon HI, Lee SM, Yoo CG, Kim YM, Han SK, Yim JJ. Monthly follow-ups of interferon-gamma release assays among health-care workers in contact with patients with TB. Chest 2012, 142:1461-1468.
15. Mahan C, Zalwango S, Thiel B, Malone LL, Chervenak K, Baseke J, Dobbs D, Stein CM, Mayanja H, Joloba ML, Whalen CC, Boom WH. Innate and adaptive immune responses during acute M. tuberculosis infection in adult household contacts in Kampala, Uganda. Am J Trop Med Hyg 2012, 86:690-697.
16. Stein CM, Hall NB, Malone LL, Mupere E. The household contact study design for genetic epidemiological studies of infectious diseases. Front Genet 2013, 4:61. doi:10.3389/fgene.2013.00061. Print;%2013.: 61.
17. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000, 161:1376-1395.
18. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000, 161:S221-S247.
19. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 1999, 159:15-21.
20. Wampande EM, Mupere E, Debanne SM, Asiimwe BB, Nsereko M, Mayanja H, Eisenach K, Kaplan G, Boom WH, Gagneux S, Joloba ML. Long-term dominance of Mycobacterium tuberculosis Uganda family in peri-urban Kampala-Uganda is not associated with cavitary disease. BMC Infect Dis 2013, 13:484. doi:10.1186/1471-2334-13-484.: 484-13.
21. Gagneux S, Small PM. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 2007, 7:328-337.
22. Lewinsohn DA, Zalwango S, Stein CM, Mayanja-Kizza H, Okwera A, Boom WH, Mugerwa RD, Whalen CC. Whole blood interferon-gamma responses to mycobacterium tuberculosis antigens in young household contacts of persons with tuberculosis in Uganda. PLoS ONE 2008, 3:e3407.
23. Agresti A. Analysis of Ordinal Categorical Data 2010, Hoboken, NJ: Wiley & Sons.
24. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Starke JJ, Enarson DA, Donald PR, Beyers N. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004, 8:392-402.
25. Whalen CC, Chiunda A, Zalwango S, Nshuti L, Jones-Lopez E, Okwera A, Hirsch C, Peters P, Boom WH, Mugerwa RD. Immune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala, Uganda. Am J Trop Med Hyg 2006, 75:55-61.
26. Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, Hatherill M, Moyo S, Hanekom W, Mahomed H. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J 2011, 30:694-700.
27. Pai M, Menzies D. The new IGRA and the old TST: making good use of disagreement. Am J Respir Crit Care Med 2007, 175:529-531.
28. Oxlade O, Schwartzman K, Menzies D. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis 2007, 11:16-26.
29. Jaganath D, Mupere E. Childhood tuberculosis and malnutrition. J Infect Dis 2012, 206:1809-1815.
30. Mupere E, Parraga IM, Tisch DJ, Mayanja HK, Whalen CC. Low nutrient intake among adult women and patients with severe tuberculosis disease in Uganda: a cross-sectional study. BMC Public Health 2012, 12:1050. doi:10.1186/1471-2458-12-1050.: 1050-12.
31. Fennelly KP, Jones-Lopez EC, Ayakaka I, Kim S, Menyha H, Kirenga B, Muchwa C, Joloba M, Dryden-Peterson S, Reilly N, Okwera A, Elliot AM, Smith PG, Mugerwa RD, Eisenach KD, Ellner JJ. Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis. Am J Respir Crit Care Med 2012, 186:450-457.
32. Fennelly K, Martyny J, Fulton K, Orme I, Cave D, Heifets L. Cough-generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness. Am J Respir Crit Care Med 2004, 169:604-609.
33. Jones-Lopez EC, Namugga O, Mumbowa F, Ssebidandi M, Mbabazi O, Moine S, Mboowa G, Fox MP, Reilly N, Ayakaka I, Kim S, Okwera A, Joloba M, Fennelly KP. Cough aerosols of Mycobacterium tuberculosis predict new infection: a household contact study. Am J Respir Crit Care Med 2013, 187:1007-1015.